Abstract: Systems, methods, and computer-readable media are disclosed for systems and methods for automated validation and deployment of machine learning models as a service. Example methods may include determining a first request for generation of a first machine learning model, automatically generating the first machine learning model using the first set of features, automatically validating the first machine learning model, deploying the first machine learning model in a production network environment, and updating the first machine learning model using the first set of feedback signals. Methods may include determining a second request for an artificial intelligence output via the graphical user interface, determining a data input associated with the second request, selecting, based on the data input, a first large language model from a set of large language models, generating the artificial intelligence output using the first large language model, and causing presentation of the artificial intelligence output.

Abstract: On a FinTech platform, integrated blockchain networks and Interplanetary file system (IPFS) technologies provide daily servicing and reporting activities to users of the Platform. Users, such as stakeholders, customers and financial institutions, interact with the Integrated Platform through both private and public networks without a middleman. A platform user uploads information associated with a physical asset, such as a mortgage/deed, loan information, or the like, to the platform. The platform records the uploaded information, simultaneously, to a private blockchain and an IPFS of the platform. A collateralized non-fungible token (cNFT) is generated to represent the physical asset and is also recorded to the private blockchain and the IPFS. To transfer ownership external to the platform, the cNFT is converted to a public cNFT and migrated to a public blockchain.

Abstract: Methods for assessing the extent of allelic imbalance in a genomic nucleic acid sample. Methods for diagnosing cancer and determining the prognosis of a patient with cancer, including breast or prostate cancer, by assessing the extent of allelic imbalance in a genomic nucleic acid sample.